RESUMEN
PURPOSE: To clinically evaluate the efficacy and tolerability of semi-fluorinated alkane eye drops (EvoTears; URSAPHARM GmbH) as ocular surface treatment after cataract surgery in patients with evaporative dry eye disease. METHODS: This prospective, monocentric, open-label clinical trial included 40 patients undergoing cataract surgery and showing symptoms of evaporative dry eye disease as measured by the Symptom Assessment in Dry Eye (Visual Analogue Scale [VAS]) questionnaire, Ocular Surface Disease Index (OSDI), and tear break-up time (TBUT) of less than 10 seconds. EvoTears was prescribed four times a day for 5 weeks and administered 15 minutes after the standard postoperative topical anti-inflammatory regimen. The primary endpoint was the change in TBUT. Secondary endpoints included assessment of the subjective symptoms (VAS), corrected distance visual acuity (CDVA), slit-lamp examination, intraocular pressure, and Schirmer's test, which were evaluated at 1 day, 1 week, and 5 weeks postoperatively. At 5 weeks postoperatively, the tolerability and efficacy of EvoTears were evaluated by physicians and patients. RESULTS: At 5 weeks postoperatively, the median TBUT increased from 6.8 (preoperative) to 14 seconds (P < .001) and the average total corneal staining score decreased from 3.53 (preoperative) to 2.36 (P < .001). The mean CDVA improved from 0.41 (preoperative) to 0.14 logMAR (P < .001) and there was a statistically significant decrease in all scores from the VAS questionnaire at 5 weeks postoperatively. There was no statistically significant change in Schirmer's test (P = .150). CONCLUSIONS: EvoTears improved tear film, ocular surface, and subjective impressions of patients with dry eye disease 5 weeks after cataract surgery. Patients' and physicians' assessment indicated good efficacy and high tolerability of EvoTears, suggesting its suitability in postoperative management of the ocular surface in patients with dry eye disease. [J Refract Surg. 2020;36(7):474-480.].
Asunto(s)
Alcanos/administración & dosificación , Extracción de Catarata/efectos adversos , Síndromes de Ojo Seco/tratamiento farmacológico , Agudeza Visual , Anciano , Síndromes de Ojo Seco/diagnóstico , Síndromes de Ojo Seco/etiología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Soluciones Oftálmicas/administración & dosificación , Periodo Posoperatorio , Estudios ProspectivosRESUMEN
The management of ocular infections is challenging due to poor drug bioavailability and vehicle related adverse effects associated with current antibiotic eye drops. Semifluorinated alkanes (SFAs) are reportedly well-tolerated on the ocular surface and can enhance ocular drug bioavailability. Therefore, an SFA-based azithromycin suspension (SFA-AZM) was prepared and its antibacterial efficacy was compared to that of marketed azithromycin eye drops by monitoring the growth of bioluminescent Staphylococcus aureus in ex vivo ocular tissues. Corneal and conjunctival distribution of hydrophobic fluorescent dye particles from an SFA suspension (SFA-BODIPY) resulted in preferential dye localisation in the epithelial layers of both tissues. However, corneal dye absorption was significantly lower than conjunctival absorption, likely due to limited adhesion of suspended dye particles to the corneal compared to the conjunctival epithelium. In line with the dye distribution results, bacterial colonisation in the conjunctiva reduced significantly upon application of SFA-AZM with the efficacy being greater than or at least equal to the marketed azithromycin eye drops. In the cornea, all tested azithromycin eye drops reduced the rate of bacterial growth with similar efficacy. Overall, the SFA-AZM suspension tested here may provide a safe and effective alternative for the management of ocular infections by enhancing conjunctival drug absorption and thus drug efficacy.
Asunto(s)
Alcanos/administración & dosificación , Azitromicina/administración & dosificación , Córnea/efectos de los fármacos , Infecciones del Ojo/tratamiento farmacológico , Suspensiones/administración & dosificación , Animales , Antibacterianos/administración & dosificación , Disponibilidad Biológica , Conjuntiva/efectos de los fármacos , Conjuntiva/microbiología , Portadores de Fármacos/química , Infecciones del Ojo/microbiología , Interacciones Hidrofóbicas e Hidrofílicas , Soluciones Oftálmicas/administración & dosificación , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/efectos de los fármacos , PorcinosRESUMEN
Sodium houttuyfonate (SH) has been indicated to play an important antiinflammatory role. Previous studies have confirmed that SH can inhibit the NFκB pathway in lipopolysaccharide (LPS)induced mastitis in bovine mammary epithelial cells. However, the effects of SH on LPSinduced mastitis in animals should be verified to further evaluate its actual value. In the present study, the antiinflammatory effects of SH were investigated in mouse models and a mouse mammary epithelial cell line. Hematoxylin and eosin staining (H&E) showed that SH therapy significantly alleviated the pathological changes in mammary glands. Myeloperoxidase (MPO) activity analysis demonstrated that SH substantially decreased MPO activity in vivo. RTqPCR results showed that SH reduced the expression of interleukin (IL)1, IL6 and tumor necrosis factor α both in vivo and in vitro. In addition, western blot results indicated that SH suppressed the phosphorylation of nuclear factor kappalightchainenhancer of activated Bcells (NFκB) p65 protein and reduced the degradation of inhibitor of kappa light polypeptide gene enhancer in Bcells alpha protein in vivo and in vitro. These results demonstrated that SH ameliorates LPSinduced mastitis by inhibiting the NFκB pathway.
Asunto(s)
Alcanos/administración & dosificación , Inflamación/tratamiento farmacológico , Mastitis/tratamiento farmacológico , Sulfitos/administración & dosificación , Factor de Transcripción ReIA/genética , Animales , Bovinos , Modelos Animales de Enfermedad , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Inflamación/inducido químicamente , Inflamación/genética , Inflamación/patología , Lipopolisacáridos/toxicidad , Glándulas Mamarias Animales/efectos de los fármacos , Glándulas Mamarias Animales/patología , Mastitis/inducido químicamente , Mastitis/genética , Mastitis/patología , Ratones , FN-kappa B/genética , Transducción de Señal/efectos de los fármacos , Factor de Necrosis Tumoral alfa/genéticaRESUMEN
OBJECTIVE: Combination of an oviposition pheromone and an insect growth regulator for the control of vectors is an effective approach. There is a need for toxicological evaluation before its introduction. The present study evaluates the acute inhalation toxicity of n-heneicosane and its combination with diflubenzuron in a head-only inhalation exposure chamber made of glass. MATERIALS AND METHODS: A head-only inhalation exposure chamber made of glass (volume: 3.5 l) was used for exposing four rats at a time. A glass nebulizer was used for aerosolization of n-heneicosane and its combination with diflubenzuron (1:10 w/w). Nebulization pressure was 10 and 15 psi and the air flow of exposure the chamber was adjusted to 30 lpm. Male Wistar rats were acclimatized in whole body plethysmographs that were connected to volumetric flow pressure transducers by silicon tubes. The transducers were connected to an amplifier and a digitized response was recorded through an oscillograph and personal computers. Respiratory variables were recorded online. After inhalation exposure, various other parameters like survival, body weight, organ body weight index and biochemical changes were recorded for analysis. RESULTS AND DISCUSSION: Particle size determination proved that the aerosol particles were within the respirable range. LC50 of n-heneicosane and its combination with diflubenzuron was found to be more than 5 g/m3. There were minimal changes observed during exposure to n-heneicosane and also its combination with diflubenzuron on the respiratory variables. The changes were not consistent with the dose. CONCLUSION: n-Heneicosane and its combination with diflubenzuron showed low mammalian toxicity.
Asunto(s)
Alcanos/toxicidad , Repelentes de Insectos/toxicidad , Aedes , Alcanos/administración & dosificación , Animales , Corazón/efectos de los fármacos , Exposición por Inhalación , Repelentes de Insectos/administración & dosificación , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Pulmón/efectos de los fármacos , Masculino , Nebulizadores y Vaporizadores , Tamaño de los Órganos/efectos de los fármacos , Tamaño de la Partícula , Ratas , Ratas Wistar , Respiración/efectos de los fármacos , Bazo/efectos de los fármacosRESUMEN
Temporal lobe epilepsy (TLE), the most common pharmacoresistant focal epilepsy disorder, remains a major unmet medical need. Propofol is used as a short-acting medication for general anesthesia and refractory status epilepticus with issues of decreased consciousness and memory loss. Dipropofol, a derivative of propofol, has been reported to exert antioxidative and antibacterial activities. Here we report that dipropofol exerted anticonvulsant activity in a mouse model of kainic acid-induced seizures. Whole cell patch-clamp recordings of brain slices from the medial entorhinal cortex (mEC) revealed that dipropofol hyperpolarized the resting membrane potential and reduced the number of action potential firings, resulting in suppression of cortical neuronal excitability. Furthermore, dipropofol activated native tonic GABAA currents of mEC layer II stellate neurons in a dose-dependent manner with an EC50 value of 9.3 ± 1.6 µM (mean ± SE). Taken together, our findings show that dipropofol activated GABAA currents and exerted anticonvulsant activities in mice, thus possessing developmental potential for new anticonvulsant therapy. NEW & NOTEWORTHY The anticonvulsant effect of dipropofol was shown in a mouse model of kainic acid-induced seizures. Whole cell patch-clamp recordings of brain slices showed suppression of cortical neuronal excitability by dipropofol. Dipropofol activated the native tonic GABAA currents in a dose-dependent manner.
Asunto(s)
Alcanos/administración & dosificación , Anticonvulsivantes/administración & dosificación , Corteza Entorrinal/efectos de los fármacos , Neuronas/efectos de los fármacos , Fenoles/administración & dosificación , Receptores de GABA-A/fisiología , Convulsiones/tratamiento farmacológico , Ácido gamma-Aminobutírico/fisiología , Animales , Relación Dosis-Respuesta a Droga , Corteza Entorrinal/fisiología , Ácido Kaínico/administración & dosificación , Masculino , Potenciales de la Membrana/efectos de los fármacos , Ratones Endogámicos C57BL , Neuronas/fisiología , Convulsiones/inducido químicamenteRESUMEN
(+)-Discodermolide is a microtubule-stabilizing agent with potential for the treatment of taxol-refractory malignancies. (+)-Discodermolide congeners containing the C-3'-phenyl side chain of taxol (paclitaxel) were synthesized based on computational docking models predicting this moiety would fill an aromatic pocket of ß-tubulin insufficiently occupied by (+)-discodermolide, thereby conferring improved ligand-target interaction. It was recently demonstrated, however, that the C-3'-phenyl side chain occupied a different space, instead extending toward the M-loop of ß-tubulin, where it induced a helical conformation, hypothesized to improve lateral contacts between adjacent microtubule protofilaments. This insight led us to evaluate the biological activity of hybrid congeners using a panel of genetically diverse cancer cell lines. Hybrid molecules retained the same tubulin-polymerizing profile as (+)-discodermolide. Since (+)-discodermolide is a potent inducer of accelerated senescence, a fate that contributes to drug resistance, congeners were also screened for senescence induction. Flow cytometric and transcriptional analysis revealed that the hybrids largely retained the senescence-inducing properties of (+)-discodermolide. In taxol-sensitive cell models, the congeners had improved dose-response parameters relative to (+)-discodermolide and, in some cases, were superior to taxol. However, in cells susceptible to senescence, EMax increased without concomitant improvements in EC50 such that overall dose-response profiles resembled that of (+)-discodermolide.
Asunto(s)
Alcanos/administración & dosificación , Carbamatos/administración & dosificación , Lactonas/administración & dosificación , Paclitaxel/administración & dosificación , Pironas/administración & dosificación , Antineoplásicos/administración & dosificación , Relación Dosis-Respuesta a Droga , Humanos , Microtúbulos/metabolismo , Transcripción Genética/efectos de los fármacos , Tubulina (Proteína)/metabolismo , Células Tumorales CultivadasRESUMEN
PURPOSE: Corticosteroids remain the mainstay therapy for uveitis, a major cause of blindness in the working age population. However, a substantial number of patients cannot benefit from the therapy due to steroids resistance or intolerance. Tacrolimus has been used to treat refractory uveitis through systemic administration. The aim of this study was to evaluate the therapeutic potential of 0.03% tacrolimus eyedrop in mouse models of uveitis. METHODS: 0.03% tacrolimus in perfluorobutylpentane (F4H5) (0.03% Tacrolimus/SFA) was formulated using a previously published protocol. Tacrolimus suspended in PBS (0.03% Tacrolimus/PBS) was used as a control. In addition, 0.1% dexamethasone (0.1% DXM) was used as a standard therapy control. Endotoxin-induced uveitis (EIU) and experimental autoimmune uveoretinitis (EAU) were induced in adult C57BL/6 mice using protocols described previously. Mice were treated with eyedrops three times/day immediately after EIU induction for 48 h or from day 14 to day 25 post-immunization (for EAU). Clinical and histological examinations were conducted at the end of the experiment. Pharmacokinetics study was conducted in mice with and without EIU. At different times after eyedrop treatment, ocular tissues were collected for tacrolimus measurement. RESULTS: The 0.03% Tacrolimus/SFA eyedrop treatment reduced the clinical scores and histological scores of intraocular inflammation in both EIU and EAU to the levels similar to 0.1% DXM eyedrop treatment. The 0.03% Tacrolimus/PBS did not show any suppressive effect in EIU and EAU. Pharmacokinetic studies showed that 15 min after topical administration of 0.03% Tacrolimus/SFA, low levels of tacrolimus were detected in the retina (48 ng/g tissue) and vitreous (2.5 ng/ml) in normal mouse eyes, and the levels were significantly higher in EIU eyes (102 ng/g tissue in the retina and 24 ng/ml in the vitreous). Tacrolimus remained detectable in intraocular tissues of EIU eyes 6 h after topical administration (68 ng/g retinal tissue, 10 ng/ml vitreous). Only background levels of tacrolimus were detected in the retina (2-8 ng/g tissue) after 0.03% Tacrolimus/PBS eyedrop administration. CONCLUSION: 0.03% Tacrolimus/SFA eyedrop can penetrate ocular barrier and reach intraocular tissue at therapeutic levels in mouse eyes, particularly under inflammatory conditions. 0.03% Tacrolimus/SFA eyedrop may have therapeutic potentials for inflammatory eye diseases including uveitis.
Asunto(s)
Inflamación/tratamiento farmacológico , Soluciones Oftálmicas/administración & dosificación , Tacrolimus/administración & dosificación , Uveítis/tratamiento farmacológico , Alcanos/administración & dosificación , Alcanos/efectos adversos , Animales , Humor Acuoso/efectos de los fármacos , Modelos Animales de Enfermedad , Ojo/efectos de los fármacos , Ojo/patología , Humanos , Inflamación/patología , Ratones , Ratones Endogámicos C57BL , Uveítis/patologíaRESUMEN
The encapsulation of natural ingredients, such as rutin, can offer improvements in sun protection effectiveness. This strategy can provide enhanced flavonoid content and produces an improved bioactive compound with new physical and functional characteristics. As an alternative to common synthetic-based sunscreens, rutin-entrapped gelatin nanoparticles (GNPs) were designed and associated with ethylhexyl dimethyl PABA (EHDP), ethylhexyl methoxycinnamate (EHMC) and methoxydibenzoylmethane (BMDBM) in sunscreen formulations. The purpose of this study was to develop rutin-loaded gelatin nanoparticles and characterize their physicochemical, thermal, functional and safety properties. Rutin-loaded gelatin nanoparticles increased antioxidant activity by 74% relative to free-rutin (FR) solution. Also, this new ingredient upgraded the Sun Protection Factor (SPF) by 48%, indicating its potential as a raw material for bioactive sunscreens. The safety profile indicated that GNPs and glutaraldehyde (GTA) decreased HaCaT cell viability in a concentration/time-dependent manner. However, both blank nanoparticles (B-NC) and rutin-loaded nanoparticles (R-NC) had good performance on skin compatibility tests. These results functionally characterized rutin-loaded nanoparticles as a safe SPF enhancer in sunscreens, especially in association with UV filters.
Asunto(s)
Nanopartículas/administración & dosificación , Rutina/administración & dosificación , Protectores Solares/administración & dosificación , Administración Cutánea , Alcanos/administración & dosificación , Alcanos/química , Alcanos/farmacología , Línea Celular , Supervivencia Celular/efectos de los fármacos , Chalconas/administración & dosificación , Chalconas/química , Chalconas/farmacología , Cinamatos/administración & dosificación , Cinamatos/química , Cinamatos/farmacología , Estabilidad de Medicamentos , Femenino , Gelatina/química , Glutaral/administración & dosificación , Glutaral/química , Glutaral/farmacología , Humanos , Masculino , Nanopartículas/química , Pruebas del Parche , Propiofenonas , Rutina/química , Rutina/farmacología , Protectores Solares/química , Protectores Solares/farmacología , Rayos Ultravioleta , para-Aminobenzoatos/administración & dosificación , para-Aminobenzoatos/química , para-Aminobenzoatos/farmacologíaRESUMEN
OBJECTIVE: To investigate the in vivo inhibitory effects of sodium houttuyfonate (SH) on symptom pattern of Qi-deficiency in rats induced by infection of bacterial biofilm on rat respiratory tract. METHODS: Symptom pattern is a term used in Traditional Chinese Medicine (TCM) to define a cluster of symptoms in a medical condition. Based on the pattern, TCM therapies are administered. The symptom pattern used in this study was lung-Qi deficiency pattern identified in rats, which was induced by nasal intubation drip of Pseudomonas aeruginosa (P. aeruginosa) (two strains) to form bacterial biofilm on airway combined with stimulation of cold and fatigue. We measured the variations of the symptoms of the pattern, weight, spleen and thymus index, blood gas, lung bronchial tissue pathology and cytokine of rat in different treatments and control groups. RESULTS: The rats of SH-treatment groups had not showed typical symptoms comparing with model group in the early stage of infection. The weight, spleen and thymus index of the SH-treatment groups were significantly higher comparing with untreated model group. The SH-treatment groups also showed higher O(2) partial pressure and lower CO(2) partial pressure than model group. Furthermore, we found that the bronchopulmonary section of SH-treatment groups not showed typical pathogenic variation in model group. The comparison of cytokine concentration in different groups indicated that SH could prevent the over-production of cytokine to reduce the inflammation occurrence. CONCLUSION: In the early stage of airway infection by biofilm of P. aeruginosa, application of SH can prevent the occurrence of lung-Qi deficiency pattern.
Asunto(s)
Alcanos/administración & dosificación , Biopelículas/efectos de los fármacos , Infecciones por Pseudomonas/tratamiento farmacológico , Pseudomonas aeruginosa/fisiología , Sulfitos/administración & dosificación , Animales , Femenino , Humanos , Pulmón/microbiología , Pulmón/patología , Pulmón/fisiopatología , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/patología , Infecciones por Pseudomonas/fisiopatología , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/aislamiento & purificación , Qi , Ratas , Ratas Sprague-DawleyRESUMEN
A man who suffered from chronic pain syndrome died two days after intravenous injection of 2 ml benzine. Previous suicide attempts by drug intoxication and strangulation had failed. Death occurred due to multi-organ failure. We present the results of the clinical, morphological and toxicological examinations performed.
Asunto(s)
Alcanos/administración & dosificación , Alcanos/envenenamiento , Insuficiencia Multiorgánica/inducido químicamente , Insuficiencia Multiorgánica/patología , Suicidio , Resultado Fatal , Patologia Forense , Humanos , Inyecciones Intravenosas , Masculino , Persona de Mediana EdadRESUMEN
Microcapsules produced by interfacial polycondensation of p-phenylenediamine (PPD) and sebacoyl chloride (SC) were studied. The products were characterized in terms of morphology, mean diameter and effectiveness of dodecane encapsulation. The use of Tween 20 as dispersion stabilizer, in comparison with polyvinyl alcohol (PVA), reduced considerably the mean diameter of the microcapsules and originated smoother wall surfaces. When compared to ethylenediamine (EDA), microcapsules produced with PPD monomer were more rigid and brittle, prone to fracture during processing and ineffective retention of the core liquid. The use of diethylenetriamine (DETA) cross-linker in combination with PPD did not decrease capsule fragility. On the other hand, addition of a small fraction of oleic acid to the organic phase remarkably improved wall toughness and lead to successful encapsulation of the core-oil. Oleic acid is believed to act as a plasticizer. Its incorporation in the polymeric wall was demonstrated by FTIR and (1)H-NMR.
Asunto(s)
Alcanos/química , Cápsulas/química , Ácido Oléico/química , Fenilendiaminas/química , Tensoactivos/química , Alcanos/administración & dosificación , Composición de Medicamentos/métodos , Polisorbatos/química , Propiedades de SuperficieRESUMEN
Sodium houttuyfonate (SH) has been found to be mildly anti-pathogenetic against the planktonic and biofilm phenotypes of Pseudomonas aeruginosa. Here, we have attempted to investigate further the anti-pathogenicity of SH and EDTA-Na2 in combination and in vitro and in vivo against planktonic and biofilm phenotypes of Pseudomonas aeruginosa (16 strains), Staphylococcus aureus (13 strains) and Candida albicans (13 strains). The antimicrobial activity of SH against all three pathogens increased dramatically when it was combined with EDTA-Na2, in vitro. Toxic reactions to the drugs when administered orally were insignificant in mice; no abnormalities were observed in the internal organs, such as the lungs and kidneys. Finally, the results of in vivo studies indicate that SH could extend the lifespan of infected animals when administered in combination with EDTA-Na2. Therefore, the results of the present study lead us to suggest that SH could be a promising antimicrobial agent and that SH combined with EDTA-Na2 has the potential to be an excellent choice of drug for combating bacterial infections clinically.
Asunto(s)
Alcanos/administración & dosificación , Antibacterianos/administración & dosificación , Candida albicans/efectos de los fármacos , Ácido Edético/administración & dosificación , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Sulfitos/administración & dosificación , Alcanos/química , Animales , Antibacterianos/química , Candida albicans/fisiología , Sinergismo Farmacológico , Quimioterapia Combinada , Ácido Edético/química , Ratones , Pseudomonas aeruginosa/fisiología , Staphylococcus aureus/fisiología , Sulfitos/química , Resultado del TratamientoRESUMEN
Houttuynia cordata Thunb. (H. cordata) is an anti-inflammatory herbal drug that is clinically used in Asia. The essential oil obtained from H. cordata is known to contain 2-undecanone (2-methyl nonyl ketone). In addition, sodium houttuyfonate is a compound that can be derived from H. cordata and has important clinical uses as an anti-inflammatory agent. Sodium houttuyfonate can be converted to decanoyl acetaldehyde (houttuynin) and then to 2-undecanone. Therefore, the experiments described here explore the comparative anti-inflammatory activities of these compounds. Sodium houttuyfonate showed more potent anti-inflammatory activities than that of 2-undecanone at the same dosage, both in vitro and in vivo, although both compounds significantly inhibited the production of tumor necrosis factor-α (TNF-α), interleukin-1ß (IL-1ß) and the expression of toll-like receptor 4 (TLR4), but increased the secretion of interleukin-10 (IL-10) in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. In addition, both compounds showed dose-dependent inhibitory effects on xylene-induced mouse ear edema. In a previous study, we found sodium houttuyfonate to be transformed to 2-undecanone during steam distillation (SD). Optimum therapeutic effects are related to the stability and pharmacological activity of the drugs. Consequently, we studied the stability of sodium houttuyfonate under a simulated gastrointestinal environment with the main influencing factors being solvent, temperature and pH effects. For the first time, sodium houttuyfonate and 2-undecanone were detected simultaneously in the mouse serum and the gastrointestinal tissue after oral administration. Sodium houttuyfonate is detected within a short period of time in the systemic circulation and tissues without conversion to 2-undecanone.
Asunto(s)
Alcanos/farmacología , Antiinflamatorios/farmacología , Cetonas/farmacología , Sulfitos/farmacología , Alcanos/administración & dosificación , Alcanos/química , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/química , Línea Celular , Supervivencia Celular/efectos de los fármacos , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Estabilidad de Medicamentos , Edema/inducido químicamente , Edema/tratamiento farmacológico , Edema/genética , Edema/metabolismo , Expresión Génica , Concentración de Iones de Hidrógeno , Cetonas/administración & dosificación , Cetonas/química , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Masculino , Ratones , Sulfitos/administración & dosificación , Sulfitos/química , Receptor Toll-Like 4/genética , Receptor Toll-Like 4/metabolismoRESUMEN
We identified 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted ureas as highly potent soluble epoxide hydrolase (sEH) inhibitors and orally active agents for treating chronic kidney diseases. Compound 19 exhibited excellent sEH inhibitory activity and bioavailability. When administered orally at 30 mg/kg, 19 lowered serum creatinine in a rat model of anti-glomerular basement membrane glomerulonephritis but 2,8-diazaspiro[4.5]decane-based trisubstituted ureas did not. These results suggest that 19 is an orally active drug candidate for treating chronic kidney diseases.
Asunto(s)
Alcanos/química , Descubrimiento de Drogas/métodos , Epóxido Hidrolasas/antagonistas & inhibidores , Insuficiencia Renal Crónica/enzimología , Urea/análogos & derivados , Administración Oral , Alcanos/administración & dosificación , Animales , Epóxido Hidrolasas/metabolismo , Humanos , Ratas , Insuficiencia Renal Crónica/tratamiento farmacológico , Solubilidad , Relación Estructura-Actividad , Urea/administración & dosificaciónRESUMEN
A 42-year-old woman was admitted to our ICU for acute respiratory failure due to benzine ingestion. On arrival at the hospital, the patient's consciousness level was GCS 3 and her SpO2 was 89% when receiving oxygen at 10 L/min. She was immediately intubated and placed on a ventilator. Chest X-ray and CT scanning showed a wide infiltrative pulmonary shadow bilaterally, and a diagnosis of acute respiratory distress syndrome (ARDS) was made. Subsequently, she became anuric and required haemodiafiltration on the 2nd day. Complications such as prolonged circulatory failure, liver dysfunction and disseminated intravascular coagulation (DIC) were then observed, and plasma exchange therapy was initiated. The patient's condition improved and a complete recovery ensued. The patient remained suicidal and was moved to the psychiatric ward for psychiatric support. Benzine is purified oil containing aliphatic hydrocarbons and is liquid at room temperature. In this case, the patient had already ARDS that required immediate intubation on arrival at the hospital. On this basis, aspiration of benzine into the lungs was considered to have occurred concomitantly with its ingestion, which therefore led to the complication of chemical pneumonitis in addition to that of circulatory shock, acute kidney injury, liver dysfunction and DIC.
Asunto(s)
Alcanos/envenenamiento , Insuficiencia Multiorgánica/inducido químicamente , Insuficiencia Multiorgánica/terapia , Intento de Suicidio , Adulto , Alcanos/administración & dosificación , Coagulación Intravascular Diseminada/inducido químicamente , Coagulación Intravascular Diseminada/terapia , Ingestión de Alimentos , Femenino , Hemofiltración , Humanos , Fallo Hepático Agudo/inducido químicamente , Fallo Hepático Agudo/terapia , Intercambio Plasmático , Diálisis Renal , Síndrome de Dificultad Respiratoria/inducido químicamente , Síndrome de Dificultad Respiratoria/terapia , Choque/inducido químicamente , Choque/terapia , Resultado del TratamientoRESUMEN
Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior. Over 30 million people worldwide suffer from AD and available therapies are still palliative rather than curative. Recently, Memoquin (MQ), a quinone-bearing polyamine compound, has emerged as a promising anti-AD lead candidate, mainly thanks to its multi-target profile. MQ acts as an acetylcholinesterase and ß-secretase-1 inhibitor, and also possesses anti-amyloid and anti-oxidant properties. Despite this potential interest, in vivo behavioral studies with MQ have been limited. Here, we report on in vivo studies with MQ (acute and sub-chronic treatments; 7-15 mg/kg per os) carried out using two different mouse models: i) scopolamine- and ii) beta-amyloid peptide- (Aß-) induced amnesia. Several aspects related to memory were examined using the T-maze, the Morris water maze, the novel object recognition, and the passive avoidance tasks. At the dose of 15 mg/kg, MQ was able to rescue all tested aspects of cognitive impairment including spatial, episodic, aversive, short and long-term memory in both scopolamine- and Aß-induced amnesia models. Furthermore, when tested in primary cortical neurons, MQ was able to fully prevent the Aß-induced neurotoxicity mediated by oxidative stress. The results support the effectiveness of MQ as a cognitive enhancer, and highlight the value of a multi-target strategy to address the complex nature of cognitive dysfunction in AD.
Asunto(s)
Alcanos/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Etilaminas/farmacología , Fármacos Neuroprotectores/farmacología , Alcanos/administración & dosificación , Alcanos/efectos adversos , Enfermedad de Alzheimer/fisiopatología , Péptidos beta-Amiloides/administración & dosificación , Péptidos beta-Amiloides/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Modelos Animales de Enfermedad , Etilaminas/administración & dosificación , Etilaminas/efectos adversos , Femenino , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Ratones , Actividad Motora/efectos de los fármacos , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/administración & dosificación , Fármacos Neuroprotectores/efectos adversos , RatasRESUMEN
CONTEXT: Acrostichum aureumL. (Pteridaceae), a mangrove fern, has been used as a Bangladeshi traditional medicine for a variety of diseases including peptic ulcer. OBJECTIVE: Isolation and structural elucidation of cytotoxic secondary metabolites from the methanol extract of the aerial parts of A. aureum. MATERIALS AND METHODS: Compounds were isolated using HPLC. The compound structures were elucidated by 1D and 2D NMR, MS and other spectroscopic methods using published data. The compounds were tested for their cytotoxic activity against healthy and cancer cells using the MTT assay. Active compounds were further evaluated for apoptosis-and necrosis-inducing potential against gastric cancer cells (AGS) using the FITC Annexin V apoptosis assay. RESULTS AND DISCUSSION: Seven known compounds, patriscabratine, tetracosane and 5 flavonoids (quercetin-3-O-ß-d-glucoside, quercetin-3-O-ß-d-glucosyl-(6â1)-α-l-rhamnoside, quercetin-3-O-α-l-rhamnoside, quercetin-3-O-α-l-rhamnosyl-7-O-ß-d-glucoside and kaempferol) were isolated. Patriscabratine was found moderately cytotoxic against AGS, MDA-MB-231 and MCF-7 cells with IC(50) values ranging from 69.8 to 197.3 µM. Tetracosane showed some cytotoxic activity against AGS, MDA-MB-231, HT-29 and NIH 3T3 cells with IC(50) values ranging from 128.7 to >250 µM. Patriscabratine and tetracosane displayed an apoptotic effect (10%) on AGS cells within 24 h which was increased (20%) after 48 h, and was comparable to, if not greater, than the positive control, cycloheximide. CONCLUSION: Except for quercetin-3-O-ß-d-glucoside and kaempferol; compounds were isolated for the first time from this plant and evaluated for their cytotoxic activity. The results highlight the potential of this plant as a source of bioactive compounds and provide a rationale for its traditional use in peptic ulcer treatment.
Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Flavonoides/farmacología , Extractos Vegetales/farmacología , Pteridaceae/química , Alcanos/administración & dosificación , Alcanos/aislamiento & purificación , Alcanos/farmacología , Animales , Antineoplásicos Fitogénicos/administración & dosificación , Antineoplásicos Fitogénicos/aislamiento & purificación , Apoptosis/efectos de los fármacos , Bangladesh , Línea Celular , Línea Celular Tumoral , Cicloheximida/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Flavonoides/administración & dosificación , Flavonoides/aislamiento & purificación , Células HT29 , Humanos , Concentración 50 Inhibidora , Medicina Tradicional , Ratones , Células 3T3 NIH , Componentes Aéreos de las Plantas , Extractos Vegetales/administración & dosificación , Extractos Vegetales/aislamiento & purificación , Factores de TiempoRESUMEN
AIM: To investigate the potential of houttuynin to covalently bind to proteins in vitro and in vivo and to identify the adduct structures. METHODS: Male Sprague-Dawley rats were intravenously injected with sodium houttuyfonate (10 mg/kg). The concentrations of houttuynin in blood, plasma and five tissues tested were determined using an LC/MS/MS method. The covalent binding values of houttuynin with hemoglobin, plasma and tissue proteins were measured in rats after intravenous injection of [1-(14)C]sodium houttuyfonate (10 mg/kg, 150 mCi/kg). Human serum albumin was used as model protein to identify the modification site(s) and structure(s) through enzymatic digestion and LC/MS(n) analysis. RESULTS: The drug was widely distributed 10 min after intravenous injection. The lungs were the preferred site for disposition, followed by the heart and kidneys with significantly higher concentrations than that in the plasma. The extent of covalent binding was correlated with the respective concentrations in the tissues, ranging from 1137 nmol/g protein in lung to 266 nmol/g protein in liver. Houttuynin reacted primarily with arginine residues in human serum albumin to form a pyrimidine adduct at 1:1 molar ratio. The same adduct was detected in rat lungs digested by pronase E. CONCLUSION: This study showed that the ß-keto aldehyde moiety in houttuynin is strongly electrophilic and readily confers covalent binding to tissue proteins, especially lung proteins, by a Schiff's base mechanism. The findings explain partially the idiosyncratic reactions of houttuyniae injection in clinical use.
Asunto(s)
Alcanos/metabolismo , Alcanos/farmacocinética , Sulfitos/metabolismo , Sulfitos/farmacocinética , Alcanos/administración & dosificación , Alcanos/química , Animales , Inyecciones Intravenosas , Masculino , Unión Proteica , Proteínas/metabolismo , Ratas , Ratas Sprague-Dawley , Sulfitos/administración & dosificación , Sulfitos/química , Distribución TisularRESUMEN
BACKGROUND: ES-285 (Spisulosine) is a novel marine compound with antitumor activity in preclinical studies. A phase I study was performed in patients with advanced solid tumors to determine the maximum tolerated dose (MTD), establish a safety profile, and to evaluate pharmacokinetics and efficacy of the drug. PATIENTS AND METHODS: Thirty patients from two centers were treated with a three-hour ES-285 intravenous infusion for five consecutive days, every 3 weeks. Eleven dose levels were explored. RESULTS: No dose-limiting toxicity (DLT) occurred from 2 to 81 mg/m²/day. Three patients had DLT, one each at dose levels 160, 120 and 100 mg/m²/day; all had grade 4 transaminase increases, one of whom (160 mg/m²/day) had concomitant grade 4 hepatitis and grade 3 bilirubin elevation. The MTD of this regimen was not reached due to early termination of the ES-285 phase I program, but was considered to be 80 to 100 mg/m²/day. Other toxicities included mild to moderate asthenia, nausea, vomiting, anemia, lymphopenia, and injection site reaction. Pharmacokinetic analyses showed dose proportionality on Days 1 and 5, a wide distribution and a long half-life. Seven patients (five with colorectal cancer) had stable disease (1.2-4.1 months), lasting for more than 3 months in three patients. CONCLUSIONS: Liver enzyme elevations were dose limiting for ES-285 in this administration schedule. Low antitumor activity was observed.
Asunto(s)
Alcanos/administración & dosificación , Antineoplásicos/administración & dosificación , Lípidos/administración & dosificación , Neoplasias/tratamiento farmacológico , Adulto , Anciano , Alcanos/efectos adversos , Alcanos/sangre , Alcanos/farmacocinética , Antineoplásicos/efectos adversos , Antineoplásicos/sangre , Antineoplásicos/farmacocinética , Esquema de Medicación , Femenino , Alemania , Semivida , Humanos , Infusiones Intravenosas , Lípidos/efectos adversos , Lípidos/sangre , Lípidos/farmacocinética , Masculino , Dosis Máxima Tolerada , Persona de Mediana Edad , Neoplasias/patología , España , Resultado del Tratamiento , Adulto JovenRESUMEN
OBJECTIVE: To investigate experimentally the possible antitumor effect of methanol extract (ME) of Calotropis gigantea L. (C. gigantean) root bark and its petroleum ether (PEF) and chloroform (CF) soluble fractions against Ehrlich ascites carcinoma (EAC) in Swiss albino mice. METHODS: The effects of ME (10 and 20 mg/kg), PEF (40 and 80 mg/kg) and CF (20 and 40 mg/kg) on the growth of EAC and life span of EAC bearing mice were studied. Hematological profile and biochemical parameters (SALP, SGPT and SGOT) were also estimated. RESULTS: Results of in vivo study showed a significant decrease in viable tumor cell count and a significant increase of life span in the ME and CF treated group compared to untreated one. The life span of ME and CF treated animals was significantly (P<0.05) increased by 43.90% (20 mg ME/kg) and 57.07% (40 mg CF/kg). ME and CF brought back the hematological parameter more or less normal level. ME and CF also restored the altered levels of serum alkaline phosphatase (SALP) and serum glutamate oxaloacetate transaminase (SGOT). CONCLUSIONS: Methanol extract (ME) of C. gigantea root bark and its chloroform soluble fraction (CF) possesses significant antitumor activity.